Skip to content

CLARUS THERAPEUTICS HOLDINGS, INC.

CIK 0001817944

← back to feed
Revenue (TTM)
$15.13M
+119.1% YoY Q2 Aug 2022
Net Income (TTM)
−$46.45M
−760.9% YoY Q2 Aug 2022
EPS Diluted (TTM)
−$1.13
+30.2% YoY Q2 Aug 2022
Gross Margin
80.9%
Q2 Aug 2022
Operating Margin
—
Q2 Aug 2022
Net Margin
-307.1%
Q2 Aug 2022
Free Cash Flow (TTM)
−$43.81M
Q2 Aug 2022
Cash
$19.17M
Q2 Aug 2022
Total Debt
—
Q2 Aug 2022
Shares Outstanding
52.02M sh
Q2 Aug 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings